Trade Mark Journal No.2026/037 11 September 2026

WO0000001933603 (5)

Office of origin: United States of America

Date of International Registration:11 June 2026
Date of designation in the UK: 11 June 2026
Image for mark 1933603

The mark consists of a side silhouette of a lion in gray, positioned partially in front of the outline of a hexagon in yellow-orange, all on a background designated by the color white. The colors gray and yellow-orange are claimed. The color white is not claimed.

The mark contains the colours grey and yellow-orange.

The mark consists of a side silhouette of a lion in gray, positioned partially in front of the outline of a hexagon in yellow-orange, all on a background designated by the color white. The colors gray and yellow-orange are claimed. The color white is not claimed.

International priority date claimed: 8 June 2026 (United States of America) (99871117)
Class 5
Pharmaceutical preparations for the treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical preparations for the prevention of cancer.

LeonaBio, Inc.

Representative: Kevin S. Costanza Seed Intellectual Property Law Group LLP, 701 5th Avenue, Suite 5400, Seattle WA 98104, UNITED STATES OF AMERICA